학술논문

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
Document Type
article
Source
Science. 375(6583)
Subject
Medical Microbiology
Biomedical and Clinical Sciences
Biological Sciences
Pneumonia
Vaccine Related
Lung
Prevention
Emerging Infectious Diseases
Biodefense
Immunization
Infectious Diseases
Pneumonia & Influenza
Biotechnology
2.1 Biological and endogenous factors
Aetiology
Infection
Good Health and Well Being
Amino Acid Substitution
Angiotensin-Converting Enzyme 2
Antibodies
Monoclonal
Antibodies
Viral
Antigenic Drift and Shift
Broadly Neutralizing Antibodies
Cryoelectron Microscopy
Crystallography
X-Ray
Humans
Immune Evasion
Models
Molecular
Mutation
Protein Binding
Protein Conformation
Protein Domains
Protein Interaction Domains and Motifs
Receptors
Coronavirus
SARS-CoV-2
Spike Glycoprotein
Coronavirus
General Science & Technology
Language
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern evades antibody-mediated immunity that comes from vaccination or infection with earlier variants due to accumulation of numerous spike mutations. To understand the Omicron antigenic shift, we determined cryo-electron microscopy and x-ray crystal structures of the spike protein and the receptor-binding domain bound to the broadly neutralizing sarbecovirus monoclonal antibody (mAb) S309 (the parent mAb of sotrovimab) and to the human ACE2 receptor. We provide a blueprint for understanding the marked reduction of binding of other therapeutic mAbs that leads to dampened neutralizing activity. Remodeling of interactions between the Omicron receptor-binding domain and human ACE2 likely explains the enhanced affinity for the host receptor relative to the ancestral virus.